Center for Pharmaceutical Products Safety Awarded International Anti-Corruption Management Certificate
The Center for Pharmaceutical Products Safety under the Ministry of Health has obtained the certificate of compliance with the ISO 37001:2025 international standard for anti-corruption management systems.
As you may be aware, following a legal experiment and collaborative efforts between the Ministry's internal anti-corruption control unit and the Anti-Corruption Agency, the international anti-corruption management standard ISO 37001:2016 was achieved at the end of 2025. Furthermore, the Center became one of the first in Central Asia to secure the updated version of this standard — ISO 37001:2025.

The awarding of this international certificate to the Center for Pharmaceutical Products Safety is a logical progression of these practical achievements. Over the recent period, in cooperation with the Agency, a series of practical measures have been implemented to prevent corruption risks within the Center’s operations.

Notably, more than 300 Center employees underwent training based on specialized educational programs. A comprehensive analysis of corruption risks was conducted, evaluating a total of 102 functions. Of these, 9 were identified as "high-risk" and 3 as "medium-risk," leading to the development of specific mitigation strategies. Additionally, significant milestones were reached in ensuring the openness and transparency of operations.

The Agency will continue to provide organizational and methodological support to all state bodies and organizations to enhance the effectiveness of anti-corruption efforts and implement targeted measures.